RINVOQ® (Upadacitinib) Receives Its Sixth U.S. FDA Approval

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/21/2026

1. WMT
2. ROST
3. AAP
4. NVDA
5. SPY
6. AVGO
7. SPCX
8. BJ
9. OSIS
10. QQQ

Go back to RINVOQ® (Upadacitinib) Receives Its Sixth U.S. FDA Approval
AbbVie (NYSE: ABBV) Delayed: 266.04 +4.21 (1.61%)
Previous Close $261.83    52 Week High $68.12 
Open $260.70    52 Week Low $50.71 
Day High $266.84    P/E 57.71 
Day Low $260.10    EPS $4.61 
Volume 2,349,199